Edinburgh-based angel syndicate investing in Scottish technology and life science companies with protectable IP. Leveraged £41.1m into Scottish scale-ups in 2025 (£12.8m from members) and £17.9m in H1 2026, usually alongside co-investors such as the Scottish National Investment Bank and Old College Capital.
Auto-extracted from press releases.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.